JACOBUS PHARMACEUTICAL COMPANY INC has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are EPITHERAPEUTICS APS, ENTERPRISE THERAPEUTICS LTD and NMD PHARMA AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | Israel | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Malaysia | 1 | |
#11 | Singapore | 1 | |
#12 | Taiwan | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Schiehser Guy Alan | 17 |
#2 | Shieh Hong-Ming | 13 |
#3 | Zhao Wenyi | 13 |
#4 | Jacobus David Penman | 10 |
#5 | Heffernan Gavin David | 9 |
#6 | Saionz Kurt William | 6 |
#7 | Jacobus David P | 6 |
#8 | Terpinski Jacek | 4 |
#9 | Shah Rajendra | 3 |
#10 | Jensen Norman P | 3 |
Publication | Filing date | Title |
---|---|---|
US9783497B1 | Determining degradation of 3,4-diaminopyridine | |
WO2014074775A1 | Heteroaryl derivatives and uses thereof | |
WO2014074778A1 | Aryl derivatives and uses thereof |